Image from Google Jackets

Deprescribing in psychiatry

By: Contributor(s): Publisher: New York : Oxford University Press, 2019Description: xiv, 247 pages ; 24 cmISBN:
  • 9780190654818 (pbk.) :
Subject(s): NLM classification:
  • WM 402.
Contents:
Preface p. ix Acknowledgments p. xiii I The Context for Deprescribing 1 Deprescribing in Psychiatry: An Introduction p. 3 2 Decision-Making in Deprescribing p. 23 3 Barriers to Deprescribing: Origins and Solutions p. 47 4 Nonpharmacological Aspects of Deprescribing p. 69 II The Intervention of Deprescribing 5 Wellness Approaches I: Self-Determined Strategies p. 87 6 Wellness Approaches II: Collaborative Strategies p. 103 7 The Process of Deprescribing p. 119 8 Deprescribing Antidepressant Medications in Major Depressive Disorder p. 137 9 Deprescribing Antipsychotic Medications p. 159 10 Deprescribing Mood Stabilizers p. 185 11 Deprescribing Benzodiazepines, Z-Drugs, and Stimulants p. 199 12 Concluding Thoughts and Future Directions p. 217 Appendix p. 229 Index p. 235
Summary: The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits. Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour. As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number Status Date due Barcode
Book South London and Maudsley Trust Library Shelves WM 402 GUP (Browse shelf(Opens below)) Available 023464

Includes bibliographical references.

Preface p. ix
Acknowledgments p. xiii
I The Context for Deprescribing
1 Deprescribing in Psychiatry: An Introduction p. 3
2 Decision-Making in Deprescribing p. 23
3 Barriers to Deprescribing: Origins and Solutions p. 47
4 Nonpharmacological Aspects of Deprescribing p. 69
II The Intervention of Deprescribing
5 Wellness Approaches I: Self-Determined Strategies p. 87
6 Wellness Approaches II: Collaborative Strategies p. 103
7 The Process of Deprescribing p. 119
8 Deprescribing Antidepressant Medications in Major Depressive Disorder p. 137
9 Deprescribing Antipsychotic Medications p. 159
10 Deprescribing Mood Stabilizers p. 185
11 Deprescribing Benzodiazepines, Z-Drugs, and Stimulants p. 199
12 Concluding Thoughts and Future Directions p. 217
Appendix p. 229
Index p. 235

The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits.

Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.

As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice